$BENF

Beneficient (BENF): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Beneficient (BENF) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. false 0001775734 0001775734 2026-08-05 2026-08-05 0001775734 BENF:SharesOfClassCommonStockParValue0.001PerShareMember 2026-08-05 2026-08-05 0001775734 BENF:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockParValue0.001PerShareAndOneShareOfSeriesConvertiblePreferred

Original reporting
Published Aug 11, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$BENF
Neutral
medium confidence
Mentioned
$BENF
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BENFNeutralMed
01

Why it matters

On June 26, 2026, Beneficient entered an amended and restated SEPA reducing the right to sell up to $100M and adding Yorkville advances via promissory notes convertible into BENF shares. The 8-K also specifies note economics (5% interest, potential increase to 18% on default), conversion price mechanics (lower of a fixed VWAP-based price and a 92% lowest VWAP over five days), a variable floor price ($0.89), maturity (June 30, 2027), and caps on share issuance and ownership.

02

Market read

This is a primary-source disclosure of a new equity-linked financing tranche and its conversion terms, which can reprice dilution and default-risk expectations for BENF.

03

What to watch

Conversion is constrained by an Exchange Cap and a 4.99% beneficial ownership limit, which can reduce immediate share issuance even if the instruments are convertible.

Relevance 6/10Novelty 6/10Timing: filed after-hours on Aug 11, 2026, for an Aug 5 note issuance and June 26 amended SEPA terms

Background

Beneficient previously disclosed a Standby Equity Purchase Agreement (SEPA) with Yorkville, allowing sales of up to $250M of Class A common stock over a commitment period.

Company-level read

Ticker impact

$BENFNeutralMedium confidence
Context

Beneficient filed an 8-K disclosing an amended and restated SEPA with Yorkville and issuance of $2.0M promissory notes convertible into BENF shares.

Expected impact

Near-term volatility risk for BENF as traders price dilution/financing overhang from convertible notes and the variable conversion mechanics.

Evidence & confidence

Item 2.03 is a primary disclosure of new financing instruments and terms (principal, discount, maturity, conversion price formula, 4.99% ownership cap), which can affect dilution expectations and risk premium even without an immediate cash-raise headline beyond the note proceeds.

Market effects

Highlights ongoing use of equity-linked financing (SEPA/convertible notes) by small-cap issuers, which can influence sentiment toward similar capital-raise structures.

Limited, primarily impacts US small-cap growth financing sentiment.

Low; the transaction is company-specific and tied to a private counterparty (Yorkville).

Counterpoint

The notes are relatively small ($4.0M total principal across two closings) versus the prior $250M SEPA capacity, so dilution impact may be manageable if conversions are slow.

Key entities

  • Beneficient

    Nasdaq-listed company (BENF) filing the 8-K for Item 2.03 and issuing convertible promissory notes to Yorkville.

  • YA II PN, Ltd. (Yorkville)

    Counterparty under the amended and restated SEPA that advances principal via promissory notes convertible into the issuer’s shares.

Related articles

$BENFMedAI 8/10

Beneficient Reports First Quarter Fiscal 2027 Results

Beneficient (NASDAQ: BENF) reported fiscal 2027 first-quarter results ended June 30, 2026. The company entered its first collateral management services engagement with a Texas state-chartered bank and closed primary capital commitments totaling over $16 million. Investments with fair value rose to $212.5 million. Operating expenses fell 84.3% to $12.5 million, including a $1.8 million loss-contingency accrual.

$BENFMed

Beneficient (BENF): Results of Operations and Financial Condition

Beneficient (BENF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q127earningsrelease.htm EX-99.1 Document For Immediate Release BENEFICIENT REPORTS FIRST QUARTER FISCAL 2027 RESULTS Company Enters into First Collateral Management Services Engagement, Closes More than $16 Million in Primary Capital Commitments Dallas, TX. – August 14,

$BENFMed

Beneficient Closes $7.44 Million GP Primary Capital Transaction

Beneficient (NASDAQ: BENF) said it closed a $7.44 million GP primary capital transaction with Quartus AI Fund II LP, managed by Quartus Capital Partners. As consideration, the fund received about $7.44 million of Beneficient resettable convertible preferred stock convertible into Class A common. The deal may add about $7.44 million to ExAlt loan collateral and tangible book value.

$BENFMed

Beneficient Reports Fourth Quarter & Fiscal Year Ended March 31, 2026 Results

Beneficient (NASDAQ: BENF) reported fiscal 2026 results for the year ended March 31, 2026, including a fourth-quarter increase in operating expenses to $17.5M (vs. $14.3M) tied to $3.1M non-cash impairment and a $62.8M loss contingency for the year. The company said it resolved GWG Holdings litigation, regained Nasdaq compliance, generated $51.5M gross proceeds from asset sales, and paid off HH-BDH Credit Agreement principal. It also named James Silk CEO and announced a first collateral manageme

$BENFMed

Beneficient (BENF): Results of Operations and Financial Condition

Beneficient (BENF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q426earningsrelease.htm EX-99.1 Document For Immediate Release Exhibit 99.1 BENEFICIENT REPORTS FOURTH QUARTER & FISCAL YEAR ENDED MARCH 31, 2026 RESULTS Transformative Fiscal 2026 Focused on Addressing Legacy Issues While Strengthening Foundation of the Company Benefic